Abdelhafiz, A.S.; Ali, A.; Kamel, M.M.; Ahmed, E.H.; Sayed, D.M.; Bakry, R.M.
Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2. Vaccines 2022, 10, 1462.
https://doi.org/10.3390/vaccines10091462
AMA Style
Abdelhafiz AS, Ali A, Kamel MM, Ahmed EH, Sayed DM, Bakry RM.
Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2. Vaccines. 2022; 10(9):1462.
https://doi.org/10.3390/vaccines10091462
Chicago/Turabian Style
Abdelhafiz, Ahmed Samir, Asmaa Ali, Mahmoud M. Kamel, Eman Hasan Ahmed, Douaa M. Sayed, and Rania M. Bakry.
2022. "Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2" Vaccines 10, no. 9: 1462.
https://doi.org/10.3390/vaccines10091462
APA Style
Abdelhafiz, A. S., Ali, A., Kamel, M. M., Ahmed, E. H., Sayed, D. M., & Bakry, R. M.
(2022). Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2. Vaccines, 10(9), 1462.
https://doi.org/10.3390/vaccines10091462
